- Home
- CURX vs CLRO Comparison
CURX vs CLRO Comparison
Compare CURX & CLRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CURX | CLRO |
|---|---|---|
| Founded | 2018 | 1983 |
| Country | United States | United States |
| Employees | 6 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Radio And Television Broadcasting And Communications Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7M | 8.7M |
| IPO Year | 2024 | 2018 |
Fundamental Metrics
Financial Performance| Metric | CURX | CLRO |
|---|---|---|
| Price | $6.21 | $5.08 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 11.2K | ★ 6.4M |
| Earning Date | 09-09-2025 | 11-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $46,067,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 11.59 |
| 52 Week Low | $0.21 | $1.62 |
| 52 Week High | $13.33 | $16.50 |
Technical Indicators
Market Signals| Indicator | CURX | CLRO |
|---|---|---|
| Relative Strength Index (RSI) | 66.52 | 55.29 |
| Support Level | $4.02 | $4.87 |
| Resistance Level | $7.00 | $6.41 |
| Average True Range (ATR) | 0.43 | 1.07 |
| MACD | 0.12 | 0.20 |
| Stochastic Oscillator | 100.00 | 60.06 |
Price Performance
Historical ComparisonAbout CURX Curanex Pharmaceuticals Inc
Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout. Phyto-N, is a proprietary botanical extract with chemical components and pharmacological activities that harnesses potential anti-inflammatory properties of a medicinal plant.
About CLRO ClearOne Inc. (DE)
ClearOne Inc is currently engaged in activities that consist solely of fulfilling warranty and technical support obligations on legacy products, evaluating potential Strategic Transactions, managing and liquidating remaining assets of the company's legacy operating business, collecting accounts receivable and recovering prepaid assets, satisfying outstanding liabilities, and maintaining public-company compliance.